Search Results - "Dedman, Daniel J."

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study by Voss, Erica A., Shoaibi, Azza, Yin Hui Lai, Lana, Blacketer, Clair, Alshammari, Thamir, Makadia, Rupa, Haynes, Kevin, Sena, Anthony G., Rao, Gowtham, van Sandijk, Sebastiaan, Fraboulet, Clement, Boyer, Laurent, Le Carrour, Tanguy, Horban, Scott, Morales, Daniel R., Martínez Roldán, Jordi, Ramírez-Anguita, Juan Manuel, Mayer, Miguel A., de Wilde, Marcel, John, Luis H., Duarte-Salles, Talita, Roel, Elena, Pistillo, Andrea, Kolde, Raivo, Maljković, Filip, Denaxas, Spiros, Papez, Vaclav, Kahn, Michael G., Natarajan, Karthik, Reich, Christian, Secora, Alex, Minty, Evan P., Shah, Nigam H., Posada, Jose D., Garcia Morales, Maria Teresa, Bosca, Diego, Cadenas Juanino, Honorio, Diaz Holgado, Antonio, Pedrera Jiménez, Miguel, Serrano Balazote, Pablo, García Barrio, Noelia, Şen, Selçuk, Üresin, Ali Yağız, Erdogan, Baris, Belmans, Luc, Byttebier, Geert, Malbrain, Manu L.N.G., Dedman, Daniel J., Cuccu, Zara, Vashisht, Rohit, Butte, Atul J., Patel, Ayan, Dahm, Lisa, Han, Cora, Bu, Fan, Arshad, Faaizah, Ostropolets, Anna, Nyberg, Fredrik, Hripcsak, George, Suchard, Marc A., Prieto-Alhambra, Dani, Rijnbeek, Peter R., Schuemie, Martijn J., Ryan, Patrick B.

“…Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines,…”
Get full text

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial by Lane, J Athene, Howson, Joanne, Donovan, Jenny L, Goepel, John R, Dedman, Daniel J, Down, Liz, Turner, Emma L, Neal, David E, Hamdy, Freddie C

“…Objective To investigate the feasibility of testing for prostate cancer and the prevalence and characteristics of the disease in unselected young men.Design…”
Get full text

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyResearch in context by Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, Clair Blacketer, Thamir Alshammari, Rupa Makadia, Kevin Haynes, Anthony G. Sena, Gowtham Rao, Sebastiaan van Sandijk, Clement Fraboulet, Laurent Boyer, Tanguy Le Carrour, Scott Horban, Daniel R. Morales, Jordi Martínez Roldán, Juan Manuel Ramírez-Anguita, Miguel A. Mayer, Marcel de Wilde, Luis H. John, Talita Duarte-Salles, Elena Roel, Andrea Pistillo, Raivo Kolde, Filip Maljković, Spiros Denaxas, Vaclav Papez, Michael G. Kahn, Karthik Natarajan, Christian Reich, Alex Secora, Evan P. Minty, Nigam H. Shah, Jose D. Posada, Maria Teresa Garcia Morales, Diego Bosca, Honorio Cadenas Juanino, Antonio Diaz Holgado, Miguel Pedrera Jiménez, Pablo Serrano Balazote, Noelia García Barrio, Selçuk Şen, Ali Yağız Üresin, Baris Erdogan, Luc Belmans, Geert Byttebier, Manu L.N.G. Malbrain, Daniel J. Dedman, Zara Cuccu, Rohit Vashisht, Atul J. Butte, Ayan Patel, Lisa Dahm, Cora Han, Fan Bu, Faaizah Arshad, Anna Ostropolets, Fredrik Nyberg, George Hripcsak, Marc A. Suchard, Dani Prieto-Alhambra, Peter R. Rijnbeek, Martijn J. Schuemie, Patrick B. Ryan

“…Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with…”
Get full text